Minnesota medical device giant Medtronic (NYSE:MDT) was the 1st to notify doctors of potential issues with certain of its deep-brain stimulation implants, but the FDA’s response to the warning may have been something of an overreaction, according to some observers.
Minnesota
Vascular Solutions can’t dodge illegal marketing lawsuit
Minnesota medical device maker Vascular Solutions (NSDQ:VASC) wasn’t able to dodge a federal off-label marketing lawsuit over its Vari-Lase varicose vein treatment devices, the company revealed in its latest financial report.
Australia issues warning on American Medical Systems’ urinary control systems
Australian healthcare regulators issued a safety advisory late last month on certain lots of American Medical Systems’ AMS 800 urinary control systems, warning that the devices were released on the market on the market without meeting the company’s product release criteria.
FDA makes Vascular Solutions’ catheter valve recall Class I
The FDA slapped its most serious designation on the recall of hemostasis valves made by Vascular Solutions (NSDQ:VASC).
The Minneapolis-based company last month recalled its Guardian II and Guardian II NC valves "due to a risk that air may be introduced into the device which may lead to an air embolism," according to the federal watchdog agency.
Cardiovascular Systems prices $33M offering | Wall Street Beat
Cardiovascular Systems (NSDQ:CSII) priced a public offering of some 2 million shares of CSII stock at $17.60 apiece, saying it expects to net about $33 million from the deal.
ACC.13 Roundup: A big week for Medtronic’s Symplicity high blood pressure device
Medtronic’s Irish profits rise 119% | Wall Street Beat
Urologix names new CEO | Personnel Moves
Medtronic closes strategic investment in LifeTech | Wall Street Beat
Medtronic (NYSE:MDT) said it’s closed a $66 million investment in Chinese medical device company LifeTech Scientific (HK:8122).
Uroplasty wins Medicare coverage for neuromodulation device
Urologix chief Warren returns to retirement
Medical device maker Urologix’s (NSDQ:ULGX) president & CEO Stryker Warren Jr. announced his retirement, effective at the end of this month.
Warren, who originally came out of retirement in June 2008 to take over Urologix’s corner office, will stay on as a salaried employee until March 29, 2013.